Lifesci Capital upgraded shares of Liquidia (NASDAQ:LQDA – Free Report) to a strong-buy rating in a research note published on Wednesday, Zacks.com reports. Several other equities analysts have also recently issued reports on the stock. Needham & Company LLC restated a buy rating and issued a $25.00 price target on shares of Liquidia in a […]

StockNews.com cut shares of TopBuild (NYSE:BLD – Free Report) from a buy rating to a hold rating in a research note published on Tuesday. Other equities research analysts also recently issued research reports about the stock. DA Davidson lowered their price objective on shares of TopBuild from $470.00 to $460.00 and set a buy rating […]

StockNews.com cut shares of Alcoa (NYSE:AA – Free Report) from a hold rating to a sell rating in a research note published on Tuesday morning. Other analysts also recently issued research reports about the company. Wolfe Research raised Alcoa from a peer perform rating to an outperform rating and set a $36.00 target price on […]

JPMorgan Chase & Co. cut shares of IGM Biosciences (NASDAQ:IGMS – Free Report) from a neutral rating to an underweight rating in a research report released on Tuesday, Marketbeat reports. The brokerage currently has $9.00 target price on the stock, down from their previous target price of $12.00. Several other brokerages have also commented on […]

Truist Financial lowered shares of IGM Biosciences (NASDAQ:IGMS – Free Report) from a buy rating to a hold rating in a report released on Tuesday, Marketbeat Ratings reports. The firm currently has $12.00 price objective on the stock, down from their previous price objective of $24.00. IGMS has been the topic of several other research […]

Oppenheimer initiated coverage on shares of Fiserv (NYSE:FI – Free Report) in a research note released on Tuesday morning, Marketbeat.com reports. The brokerage issued an outperform rating and a $203.00 price objective on the business services provider’s stock. Several other equities research analysts have also recently weighed in on FI. Morgan Stanley upgraded shares of […]

Morgan Stanley cut shares of JPMorgan Chase & Co. (NYSE:JPM) from an overweight rating to an equal weight rating in a report released on Monday morning, MarketBeat reports. Morgan Stanley currently has $224.00 price target on the financial services provider’s stock, up from their previous price target of $220.00. Other analysts also recently issued reports […]

Guggenheim assumed coverage on shares of Adicet Bio (NASDAQ:ACET – Free Report) in a research note issued to investors on Monday morning, MarketBeat Ratings reports. The brokerage issued a buy rating and a $7.00 price objective on the stock. A number of other research firms have also recently commented on ACET. Wedbush reiterated an outperform […]

Needham & Company LLC reiterated their buy rating on shares of Alight (NYSE:ALIT – Free Report) in a research report report published on Monday, Benzinga reports. They currently have a $9.00 price objective on the stock. Several other equities analysts also recently issued reports on ALIT. Wedbush cut their price objective on Alight from $12.00 […]

CareDx (NASDAQ:CDNA – Get Free Report) was downgraded by analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Wednesday. Other research analysts also recently issued reports about the company. Wells Fargo & Company assumed coverage on CareDx in a report on Tuesday, August 27th. They issued an “underweight” […]

StockNews.com initiated coverage on shares of Fresenius Medical Care (NYSE:FMS – Free Report) in a research note issued to investors on Monday. The firm issued a strong-buy rating on the stock. Separately, Truist Financial decreased their target price on shares of Fresenius Medical Care from $24.00 to $22.00 and set a hold rating on the […]

IGM Biosciences (NASDAQ:IGMS – Free Report) had its price target lowered by Guggenheim from $25.00 to $20.00 in a research report sent to investors on Tuesday, Benzinga reports. Guggenheim currently has a buy rating on the stock. Other analysts have also issued reports about the stock. Truist Financial lowered shares of IGM Biosciences from a […]

HC Wainwright reissued their buy rating on shares of Immunovant (NASDAQ:IMVT – Free Report) in a report issued on Monday, Benzinga reports. They currently have a $51.00 price objective on the stock. IMVT has been the subject of a number of other research reports. Oppenheimer dropped their target price on Immunovant from $50.00 to $46.00 […]

Oppenheimer assumed coverage on shares of Global Payments (NYSE:GPN – Free Report) in a research report released on Tuesday morning, StockNewsAPI reports. The brokerage issued a market perform rating on the business services provider’s stock. Other analysts have also recently issued research reports about the company. BMO Capital Markets reduced their price target on Global […]

Forte Biosciences, Inc. (NASDAQ:FBRX – Get Free Report) was the recipient of some unusual options trading activity on Wednesday. Investors purchased 30,205 call options on the company. This represents an increase of approximately 1,663% compared to the typical volume of 1,713 call options. Wall Street Analyst Weigh In Separately, Chardan Capital restated a “buy” rating […]

SM Energy (NYSE:SM – Free Report) had its price objective trimmed by Truist Financial from $46.00 to $38.00 in a research report report published on Monday, Benzinga reports. The brokerage currently has a hold rating on the energy company’s stock. A number of other analysts have also weighed in on the company. StockNews.com lowered SM […]

Wells Fargo & Company restated their underweight rating on shares of Healthcare Realty Trust (NYSE:HR – Free Report) in a report issued on Tuesday morning, Benzinga reports. They currently have a $17.00 price objective on the real estate investment trust’s stock, up from their prior price objective of $16.00. Other equities research analysts also recently […]

StockNews.com upgraded shares of Willdan Group (NASDAQ:WLDN – Free Report) from a buy rating to a strong-buy rating in a report issued on Tuesday morning. WLDN has been the subject of a number of other research reports. Wedbush began coverage on Willdan Group in a research report on Tuesday, September 3rd. They issued an outperform […]